Pediatrics Central™ is an all-in-one application that puts valuable medical information, via your mobile device or the web, in the hands of clinicians treating infants, children, and adolescents. Explore these free sample topics:
-- The first section of this topic is shown below --
Used in the treatment of reversible airway obstruction due to asthma or chronic obstructive pulmonary disease (COPD). Recommendations for management of asthma recommend that rapid-acting inhaled beta-agonist bronchodilators (not salmeterol, formoterol, arformoterol, indacaterol, olodaterol, or vilanterol) be reserved as acute relievers of bronchospasm; repeated or chronic use indicates the need for additional long-term control agents, including inhaled corticosteroids, mast cell stabilizers, long-acting bronchodilators (oral theophylline, beta2-agonists, or anticholinergics), and leukotriene modifiers (montelukast, zafirlukast).